SCHEMBL7755155

SCHEMBL7755155

Oc1cccc2cc(-c3ccccc3)c(C(F)(F)F)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
ENPP1 P22413 4/20 0.48
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
PAX8 Q06710 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
BACE1 P56817 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
BCL2L1 Q07817 1/20 0.39
HSD17B10 Q99714 1/20 0.39
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10913571 0.78 KDM4E (0.54) KDM4EADORA3ADORA2AADORA1KMT2A
SCHEMBL6665512 0.74 ADORA1 (0.47) KDM4EADORA3ADORA2AADORA1KMT2A
SCHEMBL2053931 0.72 KDM4E (0.48) KDM4EADORA3ADORA2AADORA1KMT2A
SCHEMBL6256195 0.70 KDM4E (0.57) KDM4EKMT2AMEN1ESR1ESR2
SCHEMBL10505618 0.70 ENPP1 (0.44) KDM4EENPP1LMNAPOLBADORA3
SCHEMBL5815474 0.70 TNKS (0.43) KDM4EENPP1POLBKMT2AMEN1
SCHEMBL18131793 0.70 MEN1 (0.48) KDM4EKMT2AMEN1ALDH1A1HSD17B10
SCHEMBL2274802 0.70 KDM4E (0.49) KDM4ELMNAADORA3ADORA2AADORA1
SCHEMBL3246323 0.68 METAP2 (0.56) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL4164854 0.68 ESR1 (0.47) ENPP1ESR1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087790-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-04-04 EP disclosed
WO-1999066958-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1999-12-29 WO disclosed
EP-0210084-B1 AMIDES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM RHONE-POULENC SANTE (FR) 1989-02-08 EP disclosed
EP-0210084-A1 Amides, processes for their preparation and medicaments containing them RHONE-POULENC SANTE (FR) 1987-01-28 EP disclosed